Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy"
Br J Cancer
.
2021 Mar;124(6):1177-1178.
doi: 10.1038/s41416-020-01214-8.
Epub 2020 Dec 18.
Authors
Haitang Yang
#
1
,
Sean R R Hall
#
2
,
Beibei Sun
3
,
Feng Yao
4
Affiliations
1
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, 200030, Shanghai, People's Republic of China.
2
Gillies McIndoe Research Institute, Wellington, 6021, New Zealand.
3
Institute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 200030, Shanghai, People's Republic of China.
4
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, 200030, Shanghai, People's Republic of China. feng.yao@shchest.org.
#
Contributed equally.
PMID:
33339893
PMCID:
PMC7961042
DOI:
10.1038/s41416-020-01214-8
No abstract available
Publication types
Letter
Comment
MeSH terms
B7-H1 Antigen
Humans
Mesothelioma, Malignant*
Peritoneal Neoplasms* / drug therapy
Substances
B7-H1 Antigen